NBM ANNOUNCES RECEIVING INVENTION PATENT, TITLED “PRENYLFLAVANONE COMPOUNDS FOR MODULATING DIABETES”, FROM ISRAELI’S PATENT OFFICE
The Israeli’s Patent Office approved the application of “PRENYLFLAVANONE COMPOUNDS FOR MODULATING DIABETES” from NBM for an invention patent with the certificate No. 231754. Prenylflavanone compounds have been used in NBM’s product, SugarBless, for blood sugar control.